Ubiquitin-conjugating enzyme UBE2C is highly expressed in breast microcalcification lesions

Ubiquitin-conjugating enzyme 2C (UBE2C) contributes to ubiquitin-mediated proteasome degradation of cell cycle progression in breast cancer. Microcalcification (MC) is the most common mammographic feature of early breast cancer. In this study, we evaluated whether UBE2C could be a tumor marker of ea...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2014-04, Vol.9 (4), p.e93934
Hauptverfasser: Chou, Chen-Pin, Huang, Nan-Chieh, Jhuang, Shu-Jhen, Pan, Huay-Ben, Peng, Nan-Jing, Cheng, Jiin-Tsuey, Chen, Chian-Feng, Chen, Jih-Jung, Chang, Tsung-Hsien
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Ubiquitin-conjugating enzyme 2C (UBE2C) contributes to ubiquitin-mediated proteasome degradation of cell cycle progression in breast cancer. Microcalcification (MC) is the most common mammographic feature of early breast cancer. In this study, we evaluated whether UBE2C could be a tumor marker of early breast cancer with MC found on screening mammography. UBE2C protein and mRNA expression were measured in breast core biopsy pairs of MC and adjacent non-MC breast tissue from each subject. Immunohistochemistry revealed UBE2C positivity in 69.4% of MC samples and 77.6% negativity in non-MC samples (p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0093934